AMPE earnings

ENGLEWOOD, Colo., April 27, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis in the knee and potentially other articular joints, announced that the Company will be hosting a conference call on April 28, 2022 at 8am EDT regarding the update from the Food and Drug Administration with respect to its AP-013 study.  Conference Call Details Date/Time: April 28, 2022 at 8am EDT Title: Investor Update Call - FDA Response Letter AP-01

ENGLEWOOD, Colo., March 23, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for the treatment of pain resulting from osteoarthritis, announced that the Company will be hosting its fourth quarter earnings and business update call March 29 at 4:30pm EST.  Conference Call Details Date/Time: March 29, 2022, at 4:30 pm EST Conferencing Link: https://event.on24.com/wcc/r/3683372/9CD2C8B658E56541C487F44C34E897BBAccess Code:  66744 Canada dial-in number (Toll Free): 1 833 950 0062 Canad

ENGLEWOOD, Colo., March 2, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for common inflammatory conditions, today announced positive data from the modified Intent-to-Treat (mITT) population in the Company's AP-013 study, a Phase 3 clinical trial of the company's lead candidate, Ampion™, in patients suffering from severe osteoarthritis of the knee (OAK). The AP-013 study was designed to confirm the efficacy observed in the first pivotal trial, AP-003-A, and was powered to dete

ENGLEWOOD, Colo., March 2, 2022 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for common inflammatory conditions, announced that the Company will be hosting a webinar and conference call today at 4:30pm EST to provide an update on clinical and regulatory progress in osteoarthritis of the knee.  Webinar Details Date/Time: March 2, 2022, at 4:30 pm EST Webinar Link: https://event.on24.com/wcc/r/3574331/964B6C5B80DB9EFD05CA55D0977BD0D5 Canada dial-in number (Toll Free): 1 833 950 0062 

ENGLEWOOD, Colo., Nov. 29, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a business update call with its chairman and CEO, Mike Martino, at 4:30 p.m. EST on Wednesday, Dec. 1, 2021. Investors and analysts can access via the information provided below: Webcast Link:   https://event.on24.com/wcc/r/3543501/784479B739F2EB467C477016E7FAD06A               Conference Call (listen only)   Canada dial-in number (Toll Free)

ENGLEWOOD, Colo., Nov. 23, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a conference call with its CEO and Chairman, Michael Martino, who will provide a corporate and business on Wednesday, December 1, 2021, at 4:30 pm EDT/ 2:30 pm MT. Conference Call & Webcast Wednesday, December 1, 2021, 4:30 pm EDT / 2:30 pm MT Webcast Link (listen only):         https://event.on24.com/wcc/r/3543501/784479B739F2EB467C477016E7FAD

ENGLEWOOD, Colo., Nov. 10, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunomodulatory therapies for common inflammatory conditions, today reported results for the three- and nine-month periods ended September 30, 2021 and provided a corporate overview and business update. Ms. Holli Cherevka, President and Chief Operating Officer, commented, "This quarter marked an exciting period of growth for drug development in the Ampion platform therapy, both in clinical and preclinical development. We have

ENGLEWOOD, Colo., Oct. 28, 2021 /PRNewswire/ -- Ampio Pharmaceuticals (NYSE:AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a conference call to discuss financial results for the quarter ended September 30, 2021 and provide a corporate business update on Wednesday, November 10, 2021, at 4:30 pm EDT/ 2:30 pm MT. Conference Call & Webcast:Wednesday, November 10, 2021, 4:30 pm EDT / 2:30 pm MTWebcast Link: https://event.on24.com/wcc/r/3499388/60A0DA16A47D6B146B1AA111CA7